BRIEF published on 07/29/2025 at 11:05, 4 months 6 days ago Meliodays and Celanese Collaborate on Hormone-Free IUD for Menstrual Pain Hormone-Free IUD Menstrual Pain Relief Meliodays VitalDose Platform Celanese Partnership
BRIEF published on 07/29/2025 at 11:05, 4 months 6 days ago Meliodays et Celanese collaborent sur un stérilet sans hormones pour les douleurs menstruelles Meliodays DIU Sans Hormones Soulagement Des Douleurs Menstruelles Plateforme VitalDose Partenariat Celanese
PRESS RELEASE published on 07/29/2025 at 11:00, 4 months 6 days ago Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain Meliodays Medical partners with Celanese to develop hormone-free non-contraceptive IUD for menstrual pain relief using VitalDose(R) Drug Delivery Platform Celanese Drug Delivery Menstrual Pain Meliodays Medical IUD
BRIEF published on 03/20/2025 at 09:10, 8 months 15 days ago Meliodays Medical Secures Over EUR 800,000 in Pre-Seed Financing Pre-seed Financing Menstrual Pain Meliodays Medical Local Treatment Innovative Healthcare
BRIEF published on 03/20/2025 at 09:10, 8 months 15 days ago Meliodays Medical obtient un financement de pré-amorçage de plus de 800 000 euros Financement De Pré-amorçage Meliodays Medical Douleurs Menstruelles Traitement Local Soins De Santé Innovants
PRESS RELEASE published on 03/20/2025 at 09:05, 8 months 15 days ago Meliodays Medical announces the closing of a pre-seed financing round of over EUR 800,000 Meliodays Medical announces successful closure of over EUR 800,000 pre-seed financing round led by capacura GmbH, focusing on new therapy for menstrual pain with hormone-free, local treatment Financing Hormone-free Menstrual Pain Meliodays Medical Pre-seed
Published on 12/05/2025 at 02:35, 4 hours 5 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 40 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 35 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 40 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 10 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 15 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 25 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
